Medtech companies will need to collaborate more closely with other parties in healthcare, as the aftermath of the coronavirus pandemic will have a comprehensive reach throughout the entire ecosystem. MTI speaks with Johnson & Johnson VP Raymond Fryrear, M.D. on the topic.
AdvaMed has reported that its member companies have provided $26.8 million in medical supplies, along with $4.1 million in cash donations.
The state’s attorney general said J&J put its profits “ahead of the health of millions of women”.
The deal will help J&J speed up its entry into the robotics market.
The company just announced that it is restructuring its global supply chain.
The deal is pending acceptance by Johnson & Johnson.
The deal is part of Johnson & Johnson’s strategy to grow its vision care business.
IBM’s Watson Health Unit is forming several collaborations to facilitate personalized health on a massive scale.